Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Opdivo in Hospitalized COVID-19 Patients
NCT04343144Phase 2Unknown
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Apr 2020
- Primary completion
- Jul 2020
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of nivolumab in coronavirus disease 2019 (COVID-19), sponsored by Assistance publique - Hôpitaux de Paris. Status: unknown.
02
Drugs
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04343144.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04343144.